Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
X8sPJgHV8ZCzwnr4
